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Abstract The C-type natriuretic peptide from the platypus
venom (OvCNP) exists in two forms, OvCNPa and OvCNPb,
whose amino acid sequences are identical. Through the use of
nuclear magnetic resonance, mass spectrometry, and peptidase
digestion studies, we discovered that OvCNPb incorporates a
D-amino acid at position 2 in the primary structure. Peptides
containing a D-amino acid have been found in lower forms of
organism, but this report is the ¢rst for a D-amino acid in a
biologically active peptide from a mammal. The result implies
the existence of a speci¢c isomerase in the platypus that con-
verts an L-amino acid residue in the protein to the D-con-
¢guration. ' 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Peptides containing D-amino acids are commonly associated
with proteins produced by phylogenetically lower forms of
organism such as bacteria and yeast. It has long been accepted
that such peptides are not present in higher order organisms
including mammals. In recent years, however, there have been
several reports of the existence of peptides that contain
D-amino acids in multicellular organisms such as frogs [1^3],
molluscs [4^6], crustaceans [7,8], and spiders [9,10]. These un-
usual peptides in metazoans are thought be produced post-
translationally, requiring a speci¢c isomerase (racemase) to
convert them from the usual L- to the D-con¢guration [1,2].
It is of great interest to know if D-amino-acid-containing pep-
tides or proteins are present in higher order organisms such as
mammals.
The venom of the Australian platypus contains a C-type
natriuretic peptide (OvCNP) that has been shown, by re-
verse-phase high performance liquid chromatography (RP-
HPLC), to exist in two forms, OvCNPa and OvCNPb
[11,12] (Fig. 1). OvCNP is the most biologically active peptide
yet identi¢ed in platypus venom. This 39-residue peptide
shares high sequence similarity with mammalian C-type na-
triuretic peptides [13] and has been implicated in the ability of
the venom to relax rat uterine smooth muscle, cause oedema
and promote mast cell histamine release. Until this study, the
basis for the di¡erent chromatographic behaviour of the two
forms of OvCNP remained unclear, but there was strong evi-
dence from earlier studies to suggest that structural heteroge-
neity was localised in the region encompassing the ¢rst 11 res-
idues of the N-terminus [11]. It was hypothesised that the
heterogeneity may be caused by proline cis^trans isomerism
since there are three proline residues in this N-terminal part of
the peptide. This argument was weak because the two forms
do not reversibly interconvert and the synthetic protein always
elutes with the same retention time as OvCNPa.
Following the determination of the conformations of
OvCNPa in aqueous solution and in sodium dodecyl sulphate
micelles [14], we performed nuclear magnetic resonance
(NMR) experiments to explain the di¡erence between the
two forms of OvCNP. In this paper, we demonstrate for the
¢rst time that a biologically active peptide that contains a
D-amino acid residue exists in a mammal, the Australian pla-
typus.
2. Materials and methods
2.1. Separation and puri¢cation of peptides
Separation of the platypus venom components was achieved by
using RP-HPLC on a GBC HPLC system with LC 1110 pumps con-
trolled by a DP 800 work station (Victoria, Australia). Details of this
procedure are described elsewhere [15]. The RP-HPLC ¢ndings of De
Plater and co-workers [11,12] showed that the amount of OvCNPa in
the whole venom was about half that of OvCNPb. For the particular
venom sample used in this study, it was found that the OvCNPa was
substantially less than OvCNPb. Thus, only OvCNPb was puri¢ed for
NMR study while OvCNPa was chemically synthesised. Several RP-
HPLC experiments were performed in order to obtain su⁄cient
OvCNPb for the NMR experiments. The OvCNPb NMR sample
contained V0.5 mg of peptide in 0.30 ml of 90% H2O/10% D2O
and pH 3.
2.2. Synthesis of OvCNPa and D-Leu2-OvCNP
Both of these peptides were synthesised manually on a 0.50 mmol
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scale using 2-(1H-benzotriazol-1-yl-)1,1,3,3-tetramethyluronium hexa-
£uorophosphate activation of Boc-amino acids with in situ neutrali-
sation chemistry as previously described [16]. Following HF cleavage,
the reduced peptides were isolated and puri¢ed using RP-HPLC using
a C4 column. Disulphide formation was carried out in 100 mM am-
monium acetate (pH 7.5) and the ¢nal puri¢ed products were isolated
by preparative RP-HPLC as follows: fractions were collected, based
on monitoring the column e¥uent at 230 nm. Those fractions shown
by electrospray mass spectrometry analysis to contain solely the target
peptide were combined and lyophilised. The OvCNPa NMR sample
was prepared by dissolving 4.8 mg of the lyophilised peptide in 0.37 ml
of 90% H2O/10% D2O, resulting in a ¢nal protein concentration of
3.1 mM and pH 3.0; the D-Leu2-OvCNP NMR sample was prepared
in the same fashion but the sample contained 3.0 mg (2.0 mM) of
peptide.
2.3. NMR spectroscopy
All NMR experiments were performed at 25‡C on a Bruker
AVANCE-600 DRX spectrometer using a 5-mm 1H inverse probe.
Two-dimensional (2D) NMR spectra were acquired in phase-sensitive
mode using time-proportional phase detection [17]. The homonuclear
2D spectra that were recorded for the OvCNPa and OvCNPb were
total correlation spectroscopy (TOCSY) [18], with spin-lock periods of
60 ms, and nuclear Overhauser enhancement spectroscopy [19] with
mixing times of 200 ms. Double-quantum-¢ltered scalar correlated
spectroscopy [20] spectra, with a phase cycle modi¢ed for fast recycle
times [21], were recorded for OvCNPa to aid in resonance assignment.
Solvent-signal suppression was achieved either by presaturation or by
using the WATERGATE [22] pulse sequence. Spectra were processed
using XWIN-NMR software (Bruker) and were analysed using the
program XEASY [23].
2.4. Digestion by leucine aminopeptidase (LAP)
The NMR samples used previously were also used in this part of
the study. The peptide digestion was begun by simultaneously mixing
20^50 Wl of the peptide samples, 500 Wl of 50 mM Tris pH 8.5, and
50 Wl of 1 mg/ml LAP. The mixtures were then maintained at 25‡C for
a speci¢ed period after which the OvCNPa sample was injected into
an Phenomenex Jupiter HPLC C18 column attached to a Thermo-
quest LCQ classic mass spectrometer (San Jose, CA, USA). The same
procedure was then applied to the sample that contained OvCNPb.
Since the HPLC run took approximately 45 min, the second sample,
OvCNPb, underwent an extra period of digestion by LAP before the
analysis. 3. Results and discussions
NMR experiments on both OvCNPa and OvCNPb showed
that chemical shifts, or positions of proton signals, in three
proline residues in OvCNPb were similar to those of OvCNPa
thus disproving the hypothesis that the heterogeneity is caused
by proline cis^trans isomerism [11]. Surprisingly, we discov-
ered that there were signi¢cant di¡erences between the chem-
ical shifts of some protons of residues 1^5 in the OvCNPa and
OvCNPb. The discrepancy was more pronounced in the HK
and NH chemical shift values of residues 2 and 3, suggesting
that the structural di¡erence between the two forms is local-
ised in the region that spans residues 2 and 3 (Fig. 2).
What causes the di¡erence between OvCNPa and
OvCNPb? It is worth noting that De Plater and co-workers
had previously shown that there is a peculiar conformation or
a ‘modi¢ed’ amino acid in the section of OvCNPb near His3
and Asp4, because the peptide bond between the two residues
was not cleaved by endoproteinase Asp-N [11]. The only plau-
sible explanation for this outcome that is consistent with the
NMR results is that a D-amino acid exists at positions 2 or 3
(or both) in OvCNPb. NMR alone cannot unambiguously
prove the existence of a D-amino acid or even pinpoint its
exact location in the sequence of residues. Other experimental
techniques were needed to establish this unusual peptide con-
formation, if it really existed.
The possibility of a D-amino acid residing in the ¢rst few
Fig. 1. RP-HPLC chromatogram of complete platypus venom. The
venom contains many protein components which are unique and
are not found elsewhere in Biology. The labelled peaks are from
peptides that exist in two isomeric forms. OvCNPa, Ornithorhynchus
venom C-type natriuretic peptide A; OvCNPb, Ornithorhynchus ven-
om C-type natriuretic peptide B; DLP-2, defensin-like peptide 2;
DLP-4, defensin-like peptide 4.
Fig. 2. Proton NMR chemical shift di¡erences between OvCNPa
and OvCNPb. A: HK chemical shift di¡erence. B: NH chemical
shift di¡erence. Values were obtained by subtracting the chemical
shifts of the proton resonances of OvCNPb from those of OvCNPa.
The HK of Lys17 of OvCNPb and the NH of Lys17 of OvCNPa
and OvCNPb were not detected in the NMR spectra so were not
included in the plot.
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residues of OvCNPb was tested by digesting both OvCNPa
and OvCNPb with LAP and then analysing the products
formed afterwards by mass spectrometry. It was postulated
that the digestion of the peptide by LAP would be hindered
by the presence of the D-amino acid in the peptide molecule.
We found that there was an about ¢ve-fold lower rate of
digestion of OvCNPb, compared with OvCNPa. Fig. 3 shows
the mass spectrum obtained after exposing OvCNPa and
OvCNPb to LAP for 1 and 1.75 h, respectively. For OvCNPa,
three major peptide peaks with molecular masses of 4206,
4093 and 3979 were present after 1 h of exposure to LAP,
indicating signi¢cant amounts of remaining intact OvCNPa,
and fragments cleaved by one and two amino acid residues
from the N-terminus. Digestion of OvCNPb for 1.75 h re-
sulted in a peak at 4093 mass units that was only V10% as
intense as the main peak at 4206, while a peak at 3979 was
not present at all. Considering that OvCNPb was exposed to
LAP for longer than OvCNPa, we can readily state that the
rate of digestion of OvCNPb by LAP is considerably less than
that of OvCNPa. Thus, it is likely that a D-amino acid residue
is present near the N-terminus of OvCNPb. The subsequent
chiral chromatography experiment provided data that were in
clear agreement with this.
To ultimately prove the existence of a D-amino acid in
OvCNPb and to determine its exact location in the amino
acid sequence, we chemically synthesised OvCNP analogues,
containing D-amino acids at positions 1, 2 and 3. RP-HPLC
showed that the D-Leu2 OvCNP analogue eluted with the
same retention time (chromatogram position) as OvCNPb;
thus it was concluded that a D-leucine was highly likely to
be present at the second position of OvCNPb. The subsequent
1D and 2D NMR experiments ¢nally proved beyond doubt
that the D-Leu2 OvCNP analogue was indeed OvCNPb (Fig.
4).
The functional signi¢cance of the D-amino acid in OvCNP
in the platypus venom is unclear at present. Experiments per-
formed by De Plater et al. [11,12] did not reveal any di¡erence
in activity between the two isomers; the two forms had the
same potency in elevating cGMP levels, and producing vaso-
dilatation, in cultured vascular smooth muscle. However,
OvCNP also causes oedema and mast cell histamine release,
and may have other biological activities that are yet to be
discovered. A more comprehensive pharmacological study is
therefore warranted in order to compare the spectrum of ac-
tivities of the two isoforms.
It is easy to speculate that the D-amino acid in OvCNPb is
probably important in increasing its stability to protease deg-
radation in the venom during storage in the gland prior to
envenomation. It is worth noting that various peptides that
contain D-amino acids in multicellular organisms are primarily
found in toxins. Speci¢cally, D-amino-acid-containing peptides
have been discovered in saw£y larvae and these are implicated
in the poisoning of predators that results from the ingestion of
the larvae [24]. D-Amino-acid-containing peptides are found in
the skin of the South American tree frog Phyllomedusa sau-
vagei [3], and tissues of the snail Achatina fulica [5] ; such
peptides from both species are biologically active while the
corresponding L-forms are inactive [1]. It is clear that in these
peptides, the D-amino acid plays crucial structural roles that
de¢ne their biological activities.
The existence of a D-amino acid at position 2 in the residue
sequence of a peptide is not entirely unique to the platypus.
Such unusual peptides from frog skin and neuropeptides
achatin I and fulicin from mollusc tissues all have a D-amino
acid in the second position from the N-terminus [1^3,5,6].
This occurrence implies that an isomerase similar to those
found in the above species may exist in the platypus venom
gland. Since an isomerase that acts near the C-terminus of a
peptide has been found in the venom of the spider Agelenopsis
aperta [9,10], it would be logical to test for such an isomerase
that operates near the N-terminus in the platypus venom. It
will also be interesting to determine if other D-amino-acid-
containing peptides are present in platypus venom. Further-
more, defensin-like peptide (DLP)-2, whose three-dimensional
structure has recently been determined [25], has an isomer
(DLP-4) with the same molecular mass. The basis for this
structural heterogeneity is not yet known so it would be im-
portant to determine if a D-amino acid is present in one of the
two DLPs.
D-Aspartate residues have been found in aged mammalian
lens proteins, but their functional signi¢cance is unknown
[26,27]. Their occurrence has been attributed to the ‘natural’
ageing process and is linked to the many posttranslational
Fig. 3. Mass spectra of OvCNPa and OVCNPb digested with LAP.
A: OvCNPa after digestion for 1 h. B: OvCNPb after digestion for
1.75 h. Peaks with molecular masses of 4206, 4093, and 3979 units
correspond to proteins that were uncleaved, cleaved by one N-termi-
nal residue, and cleaved by two N-terminal residues, respectively.
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modi¢cations that the long-lived K-crystallins can undergo
[26]. Perhaps the most important development in the search
for D-amino acids in mammalian metabolism and protein
structures is the discovery of D-aspartate and D-serine as
free amino acids in the mammalian nervous system [28,29].
D-Serine interacts with the glycine site of glutamate/N-methyl-
D-aspartate receptor causing activation of the receptor [30].
4. Conclusion
This present study has shown for the ¢rst time that a D-
amino-acid-containing biologically active peptide is present in
a mammalian system. As discussed, this unusual peptide is
likely to have an important functional role in platypus venom.
It would not be surprising therefore that many of these types
of protein/peptide isoforms will be discovered in other higher
order organisms in the future. Clearly, D-amino acids are uti-
lised more extensively in living systems than previously
thought.
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